IRIS
MORBIDELLI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.172
EU - Europa 10.788
AS - Asia 6.259
SA - Sud America 1.057
Continente sconosciuto - Info sul continente non disponibili 362
AF - Africa 229
OC - Oceania 12
Totale 33.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.976
GB - Regno Unito 2.236
CN - Cina 2.038
IT - Italia 1.946
RU - Federazione Russa 1.780
SG - Singapore 1.775
IE - Irlanda 1.361
BR - Brasile 884
VN - Vietnam 865
SE - Svezia 804
UA - Ucraina 797
FR - Francia 635
DE - Germania 520
HK - Hong Kong 507
KR - Corea 326
FI - Finlandia 300
IN - India 214
TR - Turchia 111
CA - Canada 105
BD - Bangladesh 99
NL - Olanda 90
ES - Italia 65
ZA - Sudafrica 65
AR - Argentina 61
PL - Polonia 59
NG - Nigeria 49
IQ - Iraq 47
MX - Messico 47
JP - Giappone 43
AT - Austria 41
BE - Belgio 37
ID - Indonesia 34
CI - Costa d'Avorio 26
PK - Pakistan 25
CL - Cile 23
KE - Kenya 23
CO - Colombia 22
EC - Ecuador 22
UZ - Uzbekistan 17
GR - Grecia 16
IL - Israele 16
PH - Filippine 14
SA - Arabia Saudita 14
AZ - Azerbaigian 13
LT - Lituania 13
MA - Marocco 13
VE - Venezuela 13
CZ - Repubblica Ceca 12
DZ - Algeria 12
JO - Giordania 12
NP - Nepal 12
AU - Australia 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
JM - Giamaica 10
PY - Paraguay 10
EG - Egitto 9
LB - Libano 9
PE - Perù 9
PT - Portogallo 9
IR - Iran 8
UY - Uruguay 8
ET - Etiopia 7
RS - Serbia 7
KG - Kirghizistan 6
LU - Lussemburgo 6
OM - Oman 6
AL - Albania 5
BO - Bolivia 5
BY - Bielorussia 5
CH - Svizzera 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GE - Georgia 5
RO - Romania 5
CR - Costa Rica 4
EE - Estonia 4
GT - Guatemala 4
LK - Sri Lanka 4
PA - Panama 4
BH - Bahrain 3
CY - Cipro 3
EU - Europa 3
HR - Croazia 3
KH - Cambogia 3
KZ - Kazakistan 3
MM - Myanmar 3
MY - Malesia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
HN - Honduras 2
HU - Ungheria 2
IS - Islanda 2
MT - Malta 2
NO - Norvegia 2
Totale 33.492
Salva come PNG Salva come JPEG
Città #
Southend 1.970
Dallas 1.773
Fairfield 1.660
Dublin 1.337
Ashburn 1.249
Singapore 1.067
Woodbridge 783
Chandler 742
Seattle 671
Jacksonville 651
Wilmington 626
Cambridge 577
Houston 567
Santa Clara 513
San Jose 487
Milan 486
Hong Kong 478
Moscow 468
Beijing 420
Council Bluffs 389
Hefei 376
Ann Arbor 342
Seoul 322
Princeton 261
The Dalles 247
Siena 243
Ho Chi Minh City 240
Nanjing 208
Hanoi 198
Rome 189
Los Angeles 170
Lauterbourg 142
Florence 135
New York 125
Dong Ket 115
Columbus 113
Helsinki 113
Boardman 100
San Diego 99
Fremont 94
Buffalo 87
San Mateo 85
Nanchang 80
Munich 72
São Paulo 62
Tianjin 55
Johannesburg 54
Shenyang 54
Bengaluru 53
Izmir 51
Redondo Beach 49
Warsaw 47
Chicago 46
Abuja 44
Pune 44
Da Nang 42
London 42
Figino 41
Changsha 39
Menlo Park 39
Orem 38
Turku 37
Dearborn 36
Málaga 36
Brussels 35
San Francisco 35
Kunming 34
Tokyo 34
Brooklyn 33
Frankfurt am Main 32
Shanghai 32
Haiphong 31
Hebei 31
Naples 30
Nuremberg 30
Atlanta 29
Chennai 27
Lappeenranta 27
Turin 27
Abidjan 26
Jinan 26
Denver 25
Messina 25
Phoenix 25
Vienna 25
Belo Horizonte 24
Guangzhou 24
Amsterdam 23
Boston 23
Norwalk 23
Rio de Janeiro 23
Montreal 21
Poplar 21
Stockholm 21
Toronto 21
Zhengzhou 21
Falls Church 20
Jiaxing 20
Lancaster 20
Prato 20
Totale 22.923
Salva come PNG Salva come JPEG
Nome #
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 404
Development of novel cyclic peptides as pro-apoptotic agents 392
Studying Nitric Oxide in Endothelial Cells 384
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents 375
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 356
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 315
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 304
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects 301
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 300
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 299
Cross-talk between endogenous H2S and NO accounts for vascular protective activity of the metal-nonoate Zn(PipNONO)Cl 289
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells 284
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis 277
Divergent effects of quercetin conjugates on angiogenesis 274
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 273
Neuronal effects of a nickel-piperazine/NO donor complex in rodents 273
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 264
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 262
Anti-angiogenic effectiveness of the urokinase receptor-derived peptide UPARANT in a model of oxygen induced retinopathy 260
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 259
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 257
Anti-hypertensive property of a nickel-piperazine/NO donor in spontaneously hypertensive rats 256
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 255
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 254
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 252
Efficacy of AdipoDren ® in Reducing Interleukin-1-Induced Lymphatic Endothelial Hyperpermeability 249
Peptides derived from the histidine-proline rich glycoprotein bind copper ions and exhibit anti-angiogenic properties 249
Biological characterization of nanocomposite hydrogels 247
The metal-nonoate Ni(SalPipNONO) inhibits in vitro tumor growth, invasiveness and angiogenesis 247
Analysis of the role of chemokines in angiogenesis 246
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling 245
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 244
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 243
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 243
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 241
Impaired Cerebral Perfusion in Multiple Sclerosis: Relevance of Endothelial Factors 237
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium 237
Pharmacological modulation of endothelial function during tissue remodeling in physiopathological conditions 237
Activity of "NO-donor" or "NO-mediated" drugs 235
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 232
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 230
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 230
Cerebral circulation time is prolonged and not correlated with EDSS in multiple sclerosis patients: a study using digital subtracted angiography 229
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 223
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 222
PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis 221
Pharmacological tools for the study of H2S contribution to angiogenesis 220
Role of nitric oxide in the modulation of angiogenesis 219
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 219
The impact of microgravity and hypergravity on endothelial cells 219
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through a5b1 integrin 217
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 217
Effect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: in vivo and ex vivo analysis 216
Influence of Circulating Endothelin-1 and Asymmetric Dimethylarginine on Whole Brain Circulation Time in Multiple Sclerosis 213
Differential contribution of bradykinin receptors in angiogenesis 212
Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. 210
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 209
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 209
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 208
Angiogenesis 206
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivativederivative. Effect on the motility of vascular endothelial cells 205
Nitric oxide in tumor angiogenesis 204
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 204
The rabbit corneal pocket assay 204
Comparison of the Effect of Two Hyaluronic Acid Preparations on Fibroblast and Endothelial Cell Functions Related to Angiogenesis 204
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 204
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 203
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 200
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis 197
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 196
Erucin, a natural isothiocyanate, exerts pro-angiogenic properties in cultured endothelial cells and reverts angiogenic impairment induced by high glucose 195
New tools for the study of cGMP dependent functions: validation in VEGF induced permeability and angiogenesis 195
The corneal pocket assay 195
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 194
Molecular mechanisms of resistance to anti-angiogenic drugs 193
N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and supresses neuroblastoma tumor growth 192
Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function 190
Endothelium as a source and target of H2S to improve its trophism and function 190
In vitro and in vivo models to study chemokine regulation of angiogenesis 189
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. 188
Characterization of the Safety Profile of Sweet Chestnut Wood Distillate Employed in Agriculture 187
In vitro and in vivo activation of endothelial cells by colony-stimulating factors 186
Nitric oxide and angiogenesis 185
Protective effects of novel metal-nonoates on the cellular components of the vascular system 185
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 185
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 184
Therapeutic Potential of Anti-Angiogenic Multi-Target N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 183
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 183
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth 182
Effect of nir laser therapy by mls‐mis source on fibroblast activation by inflammatory cytokines in relation to wound healing 181
Polyphenol-based nutraceuticals for the control of angiogenesis: Analysis of the critical issues for human use 181
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting 180
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 180
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway 177
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1H-pyrazolo[3,4-d]pyrimidines 4-Amino Substituted and Their Biological Evaluation 177
NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins 176
Optimization of an Ex-Vivo Human Skin/Vein Model for Long-Term Wound Healing Studies: Ground Preparatory Activities for the 'Suture in Space' Experiment Onboard the International Space Station 175
ETB receptors promote proliferation and migration of endothelial cells 175
Molecular mechanisms of VEGF-induced angiogenesis 175
Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1 175
Totale 22.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.130 0 260 123 329 157 68 104 85 103 235 233 433
2022/20232.789 187 240 356 419 247 562 63 203 281 57 102 72
2023/20241.977 74 38 138 154 59 536 665 89 14 43 35 132
2024/20254.063 90 252 324 291 405 182 97 256 337 191 449 1.189
2025/202610.922 858 1.426 1.558 1.135 1.752 397 1.425 299 413 511 253 895
2026/20271.039 551 488 0 0 0 0 0 0 0 0 0 0
Totale 33.879